PD‐L1 expression in ROS1‐rearranged non‐small cell lung cancer: A study using simultaneous genotypic screening of EGFR, ALK, and ROS1

BACKGROUND: The aim of the current study was to investigate the prevalence and clinicopathologic characteristics of ROS1‐rearranged non‐small cell lung cancer (NSCLC) in routine genotypic screening in conjunction with the study of PD‐L1 expression, a biomarker for first‐line treatment decisions. MET...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Thorac Cancer
Autors principals: Lee, Jongmin, Park, Chan Kwon, Yoon, Hyoung‐Kyu, Sa, Young Jo, Woo, In Sook, Kim, Hyo Rim, Kim, Sue Youn, Kim, Tae‐Jung
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons Australia, Ltd 2018
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6312846/
https://ncbi.nlm.nih.gov/pubmed/30475455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12917
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars